HCID 66655388, compound → N-(2,4-dimethoxybenzyl)-3-iodo-4-[2-pyridazin-4-yl-4-(trifluoromethyl)phenoxy]-N-1,2,4-thiadiazol-5-ylbenzenesulfonamide

Participants

Role	Name	HCID	Charge
Reactant	HCID 66655388	HCID 66655388	—
Reactant	2-(Pyridazin-4-yl)-4-(trifluoromethyl)phenol	HCID 135741697	—
Product	N-(2,4-dimethoxybenzyl)-3-iodo-4-[2-pyridazin-4-yl-4-(trifluoromethyl)phenoxy]-N-1,2,4-thiadiazol-5-ylbenzenesulfonamide	HCID 66652980	—

Reaction Steps

The title compound was prepared according to Preparation 35 at 60° C. over 4 days using 2-pyridazin-4-yl-4-(trifluoromethyl)phenol (Preparation 30) and N-(2,4-dimethoxybenzyl)-4-fluoro-5-iodo-N-1,2,4-thiadiazol-5-ylbenzenesulfonamide (Preparation 37) to give the product (420 mg, 43%).

Provenance & Evidence

DOI	10.6084/m9.figshare.5104873.v1
Patent number	US09145407B2
Source dataset	uspto-grants-2015_09
ORD ID	ord-00d9b3f70b5e4aaa8a68d08a31515845
Source note	uspto-grants-2015_09